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Phosphorylation of duck gizzard caldesmon by Ca2+/phospholipid-dependent protein kinase, Ca*+/calmodulin-depen- 
dent protein kinase and casein kinase II has been investigated. The Caz+/phospholipid-dependent protein kinase incorpor- 
ates more than 3 mol phosphate per mol (140 kDa) caldesmon. All phosphorylation sites are localized in the actin- and 
calmodulin-binding peptide (4&45 kDa) supposed to be a part of the C-terminal domain of caldesmon. Casein kinase 
II phosphorylates only one site located in a short (25-27 kDa) peptide, presumably in the caldesmon N-terminal domain. 
The Ca*+/calmodulin-dependent protein kinase phosphorylates two sites located in the N- and C-terminal domains of 
caldesmon. 
Caldesmon; Calmodulin; Protein kinase; Phosphorylation; (Duck gizzard) 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Caldesmon is one of the major calmodulin- and 
actin-binding proteins, isolated from smooth mus- 
cle [ 1,2] and nonmuscular tissues [3,4]. Caldesmon 
is supposed to be involved in the Ca’+-dependent 
regulation of actin and myosin interaction [5,6]. 
The Ca2+ phospholipid-dependent protein kinase 
(so-called protein kinase C) as well as the Ca2+ 
calmodulin-dependent protein kinase copurified 
with caldesmon are able to phosphorylate 
caldesmon [7,8]. Recent data indicate that 
phosphorylation of caldesmon may take place in 
vivo [4,6]; phosphorylation may affect the 
caldesmon-dependent regulation of actin and 
myosin interaction [S]. 
The aim of the present paper was to investigate 
the phosphorylation of caldesmon by a number of 
protein kinases and to locate the sites 
phosphorylated by these enzymes. 
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Duck gizzard caldesmon was isolated according to Lynch and 
Bretscher [2]. Calmodulin purified from bovine brain [9] was 
immobilized on CNBr-activated Sepharose. Rat brain protein 
kinase C was isolated by a slightly modified [lo] method of 
Uchida and Filburn [ 1 I]. The partly purified Cal+ calmodulin- 
dependent protein kinase from rat brain was obtained as 
described by McGuinness et al. [12], in which the stage of gel 
filtration was substituted by chromatography on 
phosphocellulose performed according to Karet and Schulman 
[ 131. Casein kinases I and II were purified from rat liver cytosol 
[14]. Protein kinase activity was measured by incorporation of 
“P from [y-3LP]ATP into histone HI (for protein kinase C and 
Ca’+ calmodulin-dependent protein kinase) or casein (for ca- 
sein kinases) according to Reimann et al. 1151. Caldesmon 
phosphorylation was performed in the following media: in the 
case of protein kinase C and CaZt calmodulin-dependent pro- 
tein kinase - 25 mM Tris-HCI (pH 7.5). 5 mM MgClz, 2 mM 
dithiothreitol, 0.2 mM CaClz and either 120pg/ml of a 
sonicated suspension of soybean phospholipids or IO-20 pg/ml 
of calmodulin; in the case of casein kinases - 8 mM Tris, 
13 mM KHzPOJ, 5 mM MgClz, and 2 mM dithiothreitol. The 
ATP concentration varied from 100 to 500 pM and that of en- 
zymes from 10 to 30pg/ml; caldesmon concentration was 
0.4 mg/ml. 
Phosphorylated caldesmon was digested by a-chymotrypsin 
(l-45 mitt, 3O”C, protease/substrate weight ratio 1 : 1000) ac- 
cording to Szpacenko and Dabrowska [16]. The reaction was 
terminated by addition of phenylmethylsulfonyl fluoride to a 
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final concentration of 2 mM. The peptide mixture was 
separated on gradient (7-20%) polyacrylamide gels in the 
presence of SDS [17]. For calculation of molecular mass, the 
following marker proteins were used: caldesmon (140 kDa), 
phosphorylase (94 kDa), bovine serum albumin (67 kDa), 
ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean 
trypsin inhibitor (20.1 kDa) and lactalbumin (14.4 kDa). 
Autoradiography was performed on an RT-1 film varying the 
exposure time from 1 to 7 days. Protein concentration was 
determined either spectrophotometrically, taking ,!#z = 5 for 
caldesmon [18] and Ei% = 2 for calmodulin [16], or by the 
method of Spector [19] standardized by human serum albumin. 
3. RESULTS 
Prolonged incubation of caldesmon with protein 
kinase C led to the incorporation of 3.0-3.5 mol 
phosphate per mol(l40 kDa) protein (fig. 1). These 
data fully agree with those of Umekawa and 
Hidaka [7], suggesting that the enzyme incor- 
porates 7.7 mol phosphate per caldesmon dimer 
(300 kDa). For localization of phosphorylation 
sites, caldesmon was digested by chymotrypsin, 
and the peptides thus obtained were separated by 
SDS gel electrophoresis. Protein kinase C 
phosphorylated the sites located in both the large 
peptide (115-120 kDa) and a number of short pep- 
tides with 45, 40 and 19-21 kDa (fig.2). The 
kinetics of proteolysis indicate that the 19-21 kDa 
peptide may be the product of degradation of the 
40 and 45 kDa peptides. Among other chymotryp- 
tic peptides only those of 40-45 and 19-21 kDa 
were not adsorbed on DEAE-cellulose under the 
conditions described by Fujii et al. [3]. The same 
peptides (as well as the 115-120 kDa peptide) were 
tightly adsorbed on immobilized calmodulin in the 
presence of Ca*+ and were eluted from the column 
with EGTA-containing buffers. The experimental 
results are consistent with published data, ac- 
cording to which the C-terminal fragment of 
caldesmon (40 kDa) can interact with actin and 
Ca*+-saturated calmodulin [3,14,20]. Hence, pro- 
tein kinase C phosphorylates three sites located in 
the short (40-45 kDa) C-terminal domain pro- 
viding for caldesmon interaction with actin and 
calmodulin. This assumption is in agreement with 
the fact that calmodulin causes 40-60% inhibition 
of the Ca*+ phospholipid-dependent phosphoryla- 
tion of caldesmon. 
Casein kinase I did not phosphorylate 
caldesmon, whereas casein kinase II incorporated 
about 1 mol phosphate per mol protein (fig.1). 
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Fig.1. Phosphorylation of duck gizzard caldesmon by casein 
kinase I (I), casein kinase II (2), Ca” calmodulin-dependent 
protein kinase (3), and protein kinase C (4). 
The sites phosphorylated by this enzyme are 
located in both large (90-120 kDa) and small 
(25-27 kDa) chymotryptic peptides of caldesmon 
(fig.2). Calmodulin does not affect caldesmon 
phosphorylation catalyzed by casein kinase II. The 
enzyme does not phosphorylate sites located in the 
40-45 and 19-21 kDa peptides, i.e. in the C- 
terminal peptides of caldesmon. At the same time 
the 25-27 kDa peptides containing the sites 
phosphorylated by casein kinase II already appear 
during the earliest stages of proteolysis (fig.2). 
Thus, one may suppose that casein kinase II 
phosphorylates sites located in a rather short N- 
terminal peptide of caldesmon. 
The Ca2+ calmodulin-dependent caldesmon 
kinase described by Ngai and Walsh [8], which is 
copurified with caldesmon, incorporates 2-4 mol 
phosphate per mol protein. A similar degree of 
phosphorylation was achieved when Ca*+ 
calmodulin-dependent protein kinase purified 
from rat brain was used (fig.1). The sites 
phosphorylated by this enzyme are located in pep- 
tides of 40-45 and 19-21 kDa, i.e. in the C- 
terminal peptides of caldesmon as well as in the 
25-27 kDa peptides, i.e. presumably in the N- 
terminal peptides of caldesmon. Preliminary data 
published recently indicate that the sites 
phosphorylated by caldesmon-kinase and Ca*+ 
calmodulin-dependent protein kinase are similar or 
even identical [21]. A large excess of calmodulin 
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Fig.2. One-dimensional chymotryptic peptide maps of caldesmon phosphorylated by protein 
kinase C (a,b), CaZt calmodulin- 
dependent protein kinase (c,d), and casein kinase II (e,f). (a,c,e) Coomassie blue-stained gels; (b,d,f) autoradiograms. Lanes l-9 
represent electrophoretic patterns after 0, 1, 3, 5, 7, 10, 15, 30 and 45 min chymotrypsinolysis, respectively. 
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(calmodulin/caldesmon molar ratio, 10: 1) inhibits 
phosphorylation of sites located in the C-terminal 
peptides (40-45 kDa) and does not influence 
phosphorylation of sites located in the N-terminal 
peptides (25-27 kDa) of caldesmon. This fact 
agrees with the assumption that some of the sites 
phosphorylated by the Ca2+ calmodulin-dependent 
protein kinase are located in the calmodulin- 
binding domain of caldesmon. 
4. DISCUSSION 
The present results suggest hat three enzymes, 
i.e. protein kinase C, Ca2+ calmodulin-dependent 
protein kinase and casein kinase II, are able to 
phosphorylate caldesmon. One phosphorylation 
site is presumably located in the N-terminal frag- 
ment (25-27 kDa), whereas three are located in the 
C-terminal fragment (40-45 kDa) of caldesmon. 
The latter sites phosphorylated by protein kinase C 
and Ca2+ calmodulin-dependent protein kinase are 
located in the vicinity of the calmodulin-binding 
site of caldesmon. Therefore, under certain condi- 
tions, calmodulin can inhibit phosphorylation of 
these sites. Another group of sites phosphorylated 
by casein kinase II and Ca2+ calmodulin- 
dependent protein kinase is presumably located in 
the N-terminal fragment of caldesmon distant 
from the calmodulin-binding site; thus calmodulin 
does not interfere with the phosphorylation of 
these sites. 
Localization of the sites of phosphorylation pro- 
vides more detailed information on the domain 
organization of caldesmon discussed in the 
literature [3,16,20]. The data in fig.2 indicate that 
there are a few sites with an especially high suscep- 
tibility to chymotrypsinolysis. Hydrolysis at sites 
located in the C-terminal part of caldesmon leads 
to the formation of short peptides (19-21 and 
40-45 kDa) containing the sites phosphorylated by 
protein kinase C. The N-terminal domain of 
caldesmon also contains a site susceptible to 
chymotryptic attack. Therefore, even during the 
early stages of proteolysis of caldesmon phospho- 
rylated by casein kinase, the phosphorylated pep- 
tide of 25-27 kDa is liberated (fig.2). The central 
part of the caldesmon molecule is rather resistant 
to chymotrypsinolysis, and only long-term pro- 
teolysis causes degradation of the large central 
peptide (70-90 kDa) and the formation of short 
peptides, some of which may contain one of the 
sites phosphorylated by protein kinase C. 
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